Yes, remember, those who wanted to sell at these levels, did so in the last week, now those shares are in new strong hands, and therefore, not nearly as much buying is required to move it back up into the .30's... That's why we say that corrections are healthy, as they bring in a new level of support.
Yes that would be the professional acknowledgement to the FDA decision making by Camargo and Elite. If Nasrat releases trial info publicly on Feb 14 it would be measured as to what and how much color IMO.
News 
Market Data 
Discover 
AI
